COMBINATIONS OF THE ACTIVATOR (ACTIVATORS) OF THE RECEPTOR ACTIVATED BY THE PROLIFERATOR PEROXISIS (RAPP), AND THE INHIBITOR (INHIBITORS) OF SUCKING STERIN AND TREATMENT OF DISEASES OF VESSELS

摘要

1. A composition comprising:! (a) the compound represented by formula (II) below:! ! or a pharmaceutically acceptable salt or solvate thereof,! (b) lactose monohydrate,! (c) microcrystalline cellulose,! (d) povidone! (e) croscarmellose sodium,! (f) sodium lauryl sulfate, and! (g) magnesium stearate. ! 2. The composition according to claim 1, in which the compound represented by formula (II) means:! . ! 3. The composition according to claim 1, which includes! Component Component content, wt.% Compound of formula (II) 10 Lactose monohydrate 55 Microcrystalline cellulose 20 Povidone 4 Croscarmellose sodium salt 8 Sodium lauryl sulfate 2 Magnesium stearate 1 Total 100! 4. The composition according to claim 1, which includes! Component Component content, mg Compound of formula (II) 10 Lactose monohydrate 55 Microcrystalline cellulose 20 Povidone 4 Croscarmellose sodium salt 8 Sodium lauryl sulfate 2 Magnesium stearate 1 Total 100! 5. A composition comprising:! (a) the compound represented by formula (II) below:! ! or a pharmaceutically acceptable salt or solvate thereof,! (b) lactose! (c) cellulose, and! (d) povidone. ! 6. The composition according to claim 3, which further includes croscarmellose sodium. ! 7. A therapeutic combination including:! (a) a first amount of at least one cholesterol biosynthesis inhibitor; ! (b) a second amount of the compound represented by formula (II) below:! ! or a pharmaceutically acceptable salt or solvate thereof; ! (c) lactose monohydrate,! (d) microcrystalline cellulose,! (e) povidone! (f) croscarmellose sodium salt,! (g) sodium lauryl sulfate, and! (f) magnesium stearate,! in which the first quantity and the second quantity together include